Guillain‐Barré syndrome following COVID‐19 vaccination: An updated systematic review of cases

Guillain‐Barré syndrome following COVID‐19 vaccination: An updated systematic review of cases

Key Clinical Message Guillain‐Barré syndrome (GBS) is a rare but possible complication that may occur after COVID‐19 vaccination. In this systematic review, we found that GBS presented in patients with an average age of 58. The average time for symptoms to appear was 14.4 days. Health care providers...

Full description

Bibliographic Details
Main Authors: Nour Shaheen, Abdelraouf Ramadan, Abdulqadir J. Nashwan, Ahmed Shaheen, Shahzaib Ahmad, Karam R. Motawea, Salaheldin Mohamed, Rahma Sameh Mohamed, Sarya Swed, Hani Aiash
Format: Article
Language:English
Published: Wiley 2023-06-01
Series:Clinical Case Reports
Subjects:
COVID‐19
COVID‐19 vaccines
Guillain‐Barré syndrome (GBS)
SARS‐CoV‐2
Online Access:https://doi.org/10.1002/ccr3.7456

Similar Items

Similar Items